English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23774388      線上人數 : 732
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34414


    標題: Sanghuangporus sanghuang Mycelium Prevents Paracetamol-Induced Hepatotoxicity through Regulating the MAPK/NF-kappa B, Keap1/Nrf2/HO-1, TLR4/PI3K/Akt, and CaMKK beta/LKB1/AMPK Pathways and Suppressing Oxidative Stress and Inflammation
    作者: Jiang, Wen-Ping
    Deng, Jeng-Shyan
    Huang, Shyh-Shyun
    Wu, Sheng-Hua
    Chen, Chin-Chu
    Liao, Jung-Chun
    Chen, Hung-Yi
    Lin, Hui-Yi
    Huang, Guan-Jhong
    貢獻者: China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Coll Chinese Med
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Asia Univ, Dept Occupat Therapy
    Asia Univ, Dept Hlth & Nutr Biotechnol
    China Med Univ, Sch Pharm
    Natl Museum Nat Sci, Dept Biol
    Grape King Biotechnol Ctr
    關鍵字: Sanghuangporus sanghuang
    paracetamol
    hepatoprotective
    MAPK
    NF-kappa B pathway
    Keap1/Nrf2/HO-1 pathway
    CaMKK beta/LKB1/AMPK pathway
    anti-inflammation
    日期: 2021
    上傳時間: 2023-11-11 11:50:36 (UTC+8)
    出版者: MDPI
    摘要: Liver damage induced by paracetamol overdose is the main cause of acute liver failure worldwide. In order to study the hepatoprotective effect of Sanghuangporus sanghuang mycelium (SS) on paracetamol-induced liver injury, SS was administered orally every day for 6 days in mice before paracetamol treatment. SS decreased serum aminotransferase activities and the lipid profiles, protecting against paracetamol hepatotoxicity in mice. Furthermore, SS inhibited the lipid peroxidation marker malondialdehyde (MDA), hepatic cytochrome P450 2E1 (CYP2E1), and the histopathological changes in the liver and decreased inflammatory activity by inhibiting the production of proinflammatory cytokines in paracetamol-induced acute liver failure. Moreover, SS improved the levels of glutathione (GSH), superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase in the liver. Significantly, SS diminished mitogen-activated protein kinase (MAPK), Toll-like receptor 4 (TLR4), phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), and the nuclear factor-kappa B (NF-kappa B) axis, as well as upregulated the Kelch-like ECH-associated protein 1 (Keap1)/erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway, in paracetamol-induced mice. SS mainly inhibited the phosphorylation of the liver kinase B1 (LKB1), Ca2+/calmodulin-dependent kinase kinase beta (CaMKK beta), and AMP-activated protein kinase (AMPK) protein expression. Furthermore, the protective effects of SS on paracetamol-induced hepatotoxicity were abolished by compound C, an AMPK inhibitor. In summary, we provide novel molecular evidence that SS protects liver cells from paracetamol-induced hepatotoxicity by inhibiting oxidative stress and inflammation.
    關聯: ANTIOXIDANTS-BASEL, v.10, n.6
    顯示於類別:[藥學系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    antiox10060897.pdf4378KbAdobe PDF39檢視/開啟
    index.html0KbHTML80檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋